This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Jul;30(7):1862-4.

doi: 10.2337/dc06-2545. Epub 2007 Apr 27.

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

Arthur J Bergman¹, Josee Cote, Bingming Yi, Thomas Marbury, Suzanne K Swan, William Smith, Keith Gottesdiener, John Wagner, Gary A Herman

Affiliations

PMID: 17468348
DOI: 10.2337/dc06-2545

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

Arthur J Bergman et al. Diabetes Care. 2007 Jul.

. 2007 Jul;30(7):1862-4.

doi: 10.2337/dc06-2545. Epub 2007 Apr 27.

Authors

Arthur J Bergman¹, Josee Cote, Bingming Yi, Thomas Marbury, Suzanne K Swan, William Smith, Keith Gottesdiener, John Wagner, Gary A Herman

Affiliation

¹ Merck Research Laboratories, P.O. Box 4, WP75B-100, West Point, PA 19486, USA. arthur_bergman@merck.com

PMID: 17468348
DOI: 10.2337/dc06-2545

No abstract available

PubMed Disclaimer

Similar articles

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Herman GA, Bergman A, Yi B, Kipnes M; Sitagliptin Study 012 Group. Herman GA, et al. Curr Med Res Opin. 2006 Oct;22(10):1939-47. doi: 10.1185/030079906X132587. Curr Med Res Opin. 2006. PMID: 17022853 Clinical Trial.
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin.
Migoya EM, Stevens CH, Bergman AJ, Luo WL, Lasseter KC, Dilzer SC, Davies MJ, Wagner JA, Herman GA. Migoya EM, et al. Can J Clin Pharmacol. 2009 Winter;16(1):e165-70. Epub 2009 Feb 16. Can J Clin Pharmacol. 2009. PMID: 19221403 Clinical Trial.
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, Xu S, Elmore CS, Ciccotto S, Hora DF, Stearns RA, Vincent SH. Beconi MG, et al. Drug Metab Dispos. 2007 Apr;35(4):525-32. doi: 10.1124/dmd.106.013110. Epub 2007 Jan 12. Drug Metab Dispos. 2007. PMID: 17220241
[Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
Matthes J, Faust M. Matthes J, et al. Dtsch Med Wochenschr. 2008 Oct;133(43):2233-7. doi: 10.1055/s-0028-1091266. Epub 2008 Oct 15. Dtsch Med Wochenschr. 2008. PMID: 18924057 Review. German. No abstract available.
[Sitagliptin. Dipeptidylpeptidase 4 inhibitor for patients with diabetes mellitus type 2].
Musch A, Heinzl S. Musch A, et al. Med Monatsschr Pharm. 2007 Aug;30(8):282-6; quiz 287-8. Med Monatsschr Pharm. 2007. PMID: 17879807 Review. German. No abstract available.

See all similar articles

Cited by

The place of GLP-1-based therapy in diabetes management: differences between DPP-4 inhibitors and GLP-1 receptor agonists.
Eckerle Mize DL, Salehi M. Eckerle Mize DL, et al. Curr Diab Rep. 2013 Jun;13(3):307-18. doi: 10.1007/s11892-013-0377-9. Curr Diab Rep. 2013. PMID: 23479200 Review.
Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units.
Lohan L, Galtier F, Manson T, Mura T, Castet-Nicolas A, Faure D, Chapet N, Leclercq F, Pasquié JL, Roubille F, Roubille C, Blain H, Guilpain P, Villiet M, Avignon A, Sultan A, Breuker C. Lohan L, et al. Medicina (Kaunas). 2021 Dec 17;57(12):1376. doi: 10.3390/medicina57121376. Medicina (Kaunas). 2021. PMID: 34946320 Free PMC article.
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment.
Eligar VS, Bain SC. Eligar VS, et al. Drug Des Devel Ther. 2013 Aug 30;7:893-903. doi: 10.2147/DDDT.S32331. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24039399 Free PMC article. Review.
Evaluation and management of diabetes mellitus.
Nguyen Q, Nguyen L, Felicetta J. Nguyen Q, et al. Am Health Drug Benefits. 2008 Oct;1(8):39-48. Am Health Drug Benefits. 2008. PMID: 25126259 Free PMC article.
Application of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptin.
Naik H, Czerniak R, Vakilynejad M. Naik H, et al. Br J Clin Pharmacol. 2016 Apr;81(4):700-12. doi: 10.1111/bcp.12853. Epub 2016 Feb 22. Br J Clin Pharmacol. 2016. PMID: 26617339 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information

NODES